What's Happening?
The AACR-AstraZeneca Fellowship for Physician-Scientists is designed to support the training and career development of pathologists with a focus on digital pathology and artificial intelligence. This fellowship provides a two-year research training program,
with one year at an academic institution and another year with AstraZeneca. The program aims to offer an immersive experience in AI-driven cancer research and diagnostics, with a preference for onsite work at AstraZeneca's locations in Gaithersburg, Maryland, or Cambridge, Massachusetts. The fellowship is open to applicants enrolled in accredited pathology programs in the U.S., and there are no citizenship requirements, although applicants must be authorized to work in the U.S.
Why It's Important?
This fellowship represents a significant opportunity for physician-scientists to gain hands-on experience in both academic and industry settings, bridging the gap between research and practical application in the field of oncology. By focusing on digital and computational pathology, the program aims to advance cancer research through innovative AI technologies. This initiative could lead to significant advancements in cancer diagnostics and treatment, benefiting the healthcare industry and patients alike. The collaboration between AACR and AstraZeneca highlights the importance of industry-academic partnerships in driving scientific progress.
What's Next?
Fellows will engage in mentored research projects that could lead to independent careers in academic research or the pharmaceutical industry. The program's flexible structure allows for hybrid and remote work arrangements, depending on the fellow's project needs. As the fellowship progresses, it is expected to contribute to the development of new AI-driven methodologies in cancer research, potentially influencing future research directions and collaborations between academia and industry.
